Thus, the absence of Mlkl or Ripk3 protects mice against age-related MASLD/MASH pathology by reducing liver steatosis, fibrosis, and liver injury. This evidence concerns the gene RIPK3 and metabolic dysfunction-associated steatotic liver disease.